Literature DB >> 16609090

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

Louis Monnier1, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette.   

Abstract

CONTEXT: Glycemic disorders, one of the main risk factors for cardiovascular disease, are associated with activation of oxidative stress.
OBJECTIVE: To assess the respective contributions of sustained chronic hyperglycemia and of acute glucose fluctuations to oxidative stress in type 2 diabetes. DESIGN, SETTING, AND PARTICIPANTS: Case-control study of 21 patients with type 2 diabetes (studied 2003-2005) compared with 21 age- and sex-matched controls (studied in 2001) in Montpellier, France. MAIN OUTCOME MEASURES: Oxidative stress, estimated from 24-hour urinary excretion rates of free 8-iso prostaglandin F2alpha (8-iso PGF2alpha). Assessment of glucose fluctuations was obtained from continuous glucose monitoring system data by calculating the mean amplitude of glycemic excursions (MAGE). Postprandial contribution to glycemic instability was assessed by determining the postprandial increment of glucose level above preprandial values (mean postprandial incremental area under the curve [AUCpp]). Long-term exposure to glucose was estimated from hemoglobin A1c, from fasting glucose levels, and from mean glucose concentrations over a 24-hour period.
RESULTS: Mean (SD) urinary 8-iso PGF2alpha excretion rates were higher in the 21 patients with diabetes (482 [206] pg/mg of creatinine) compared with controls (275 [85] pg/mg of creatinine). In univariate analysis, only MAGE (r = 0.86; P<.001) and AUCpp (r = 0.55; P = .009) showed significant correlations with urinary 8-iso PGF2alpha excretion rates. Relationships between 8-iso PGF2alpha excretion rates and either MAGE or AUCpp remained significant after adjustment for the other markers of diabetic control in multiple linear regression analysis (multiple R2 = 0.72 for the model including MAGE and multiple R2 = 0.41 for the model including AUCpp). Standardized regression coefficients were 0.830 (P<.001) for MAGE and 0.700 (P = .003) for AUCpp.
CONCLUSIONS: Glucose fluctuations during postprandial periods and, more generally, during glucose swings exhibited a more specific triggering effect on oxidative stress than chronic sustained hyperglycemia. The present data suggest that interventional trials in type 2 diabetes should target not only hemoglobin A1c and mean glucose concentrations but also acute glucose swings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16609090     DOI: 10.1001/jama.295.14.1681

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  751 in total

1.  Translating glucose variability metrics into the clinic via Continuous Glucose Monitoring: a Graphical User Interface for Diabetes Evaluation (CGM-GUIDE©).

Authors:  Renata A Rawlings; Hang Shi; Lo-Hua Yuan; William Brehm; Rodica Pop-Busui; Patrick W Nelson
Journal:  Diabetes Technol Ther       Date:  2011-09-20       Impact factor: 6.118

2.  Continuous glucose monitoring to assess the ecologic validity of dietary glycemic index and glycemic load.

Authors:  Anthony N Fabricatore; Cara B Ebbeling; Thomas A Wadden; David S Ludwig
Journal:  Am J Clin Nutr       Date:  2011-11-09       Impact factor: 7.045

3.  Prediction of the risk to develop diabetes-related late complications by means of the glucose pentagon model: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring study.

Authors:  Andreas Thomas; Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

Review 4.  Impact of postprandial glycaemia on health and prevention of disease.

Authors:  E E Blaak; J-M Antoine; D Benton; I Björck; L Bozzetto; F Brouns; M Diamant; L Dye; T Hulshof; J J Holst; D J Lamport; M Laville; C L Lawton; A Meheust; A Nilson; S Normand; A A Rivellese; S Theis; S S Torekov; S Vinoy
Journal:  Obes Rev       Date:  2012-07-11       Impact factor: 9.213

5.  Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation.

Authors:  Jinling Hou; Zhao Zhong Chong; Yan Chen Shang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2010-05       Impact factor: 1.990

6.  Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes.

Authors:  Alfonso Galderisi; Jennifer Sherr; Michelle VanName; Lori Carria; Melinda Zgorski; Eileen Tichy; Kate Weyman; Eda Cengiz; Stuart Weinzimer; William Tamborlane
Journal:  J Clin Endocrinol Metab       Date:  2018-03-01       Impact factor: 5.958

7.  Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes.

Authors:  I M E Wentholt; W Kulik; R P J Michels; J B L Hoekstra; J H DeVries
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

Review 8.  Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes.

Authors:  Christine L Chan
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

9.  Dietary sugar/starches intake and Barrett's esophagus: a pooled analysis.

Authors:  Nan Li; Jessica Leigh Petrick; Susan Elizabeth Steck; Patrick Terrence Bradshaw; Kathleen Michele McClain; Nicole Michelle Niehoff; Lawrence Stuart Engel; Nicholas James Shaheen; Douglas Allen Corley; Thomas Leonard Vaughan; Marilie Denise Gammon
Journal:  Eur J Epidemiol       Date:  2017-09-01       Impact factor: 8.082

Review 10.  Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms.

Authors:  Elizabeth Guerrero-Berroa; James Schmeidler; Michal Schnaider Beeri
Journal:  Eur Neuropsychopharmacol       Date:  2014-01-30       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.